Smiths Medical Recalls Certain CADD System Administration Sets and Cassette Reservoirs for Issues Causing Delay, Interruption, or Under-Delivery of Therapy

Global Pharma Healthcare Issues Voluntary Nationwide Recall of Artificial Tears Lubricant Eye Drops Due to Possible Contamination
February 2, 2023
Other News and Announcements
February 2, 2023
Global Pharma Healthcare Issues Voluntary Nationwide Recall of Artificial Tears Lubricant Eye Drops Due to Possible Contamination
February 2, 2023
Other News and Announcements
February 2, 2023

Smiths Medical is recalling certain CADD Administration Sets and Medication Cassette Reservoirs, used with the CADD ambulatory infusion system, for two issues: a risk of tubing occlusion and a risk of false “No Disposable Attached (NDA)” alarms. Either of these issues can cause delay of therapy, interruption of therapy, or under-delivery of medication, which all have the potential to cause serious patient harm or death.

The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall.

Read more…